share_log

JonesTrading Initiates Coverage On Cullinan Oncology With Buy Rating, Announces Price Target of $22

JonesTrading Initiates Coverage On Cullinan Oncology With Buy Rating, Announces Price Target of $22

JoneStrading以买入评级开始对Cullinan Oncology进行报道,宣布目标股价为22美元
Benzinga ·  2023/10/06 05:50

JonesTrading analyst Soumit Roy initiates coverage on Cullinan Oncology (NASDAQ:CGEM) with a Buy rating and announces Price Target of $22.

琼斯交易分析师Soumit Roy以买入评级启动对库利南肿瘤学(纳斯达克:CGEM)的报道,并宣布目标价为22美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发